Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AOG | Cash or scrip for Aveo | 29/03/23 | 16 | 7.6K | |||
|
|||||||
AOG | Ann: Removal from Official List | 02/12/19 | 0 | 1.8K | |||
|
|||||||
AOG | Ann: Appendix 3Z - Mr Gregory Shaw (Alternate Director) | 29/11/19 | 0 | 1.4K | |||
|
|||||||
AOG | Ann: Final Director's Interest Notice - Mr Seng Huang Lee | 29/11/19 | 0 | 4.9K | |||
|
|||||||
AOG | Ann: Final Director's Interest Notice - Mr Walter McDonald | 29/11/19 | 0 | 670 | |||
|
|||||||
AOG | Ann: Final Director's Interest Notice - Mr Kelvin Lo | 29/11/19 | 0 | 2.6K | |||
|
|||||||
AOG | Ann: Final Director's Interest Notice - Mr Jim Frayne | 29/11/19 | 0 | 699 | |||
|
|||||||
AOG | Ann: Final Director's Interest Notice - Mr Eric Lee | 29/11/19 | 0 | 1.3K | |||
|
See All Discussions